Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program
Go back to Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.38 -0.18 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.56 | 52 Week High | $5.58 | |||
| Open | $14.53 | 52 Week Low | $3.60 | |||
| Day High | $14.64 | P/E | N/A | |||
| Day Low | $14.36 | EPS | $0.00 | |||
| Volume | 8,677,539 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 44.37 +0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.36 | 52 Week High | $44.76 | |||
| Open | $45.08 | 52 Week Low | $36.81 | |||
| Day High | $45.23 | P/E | N/A | |||
| Day Low | $44.21 | EPS | $0.00 | |||
| Volume | 2,015,192 | |||||
